We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bristol-Myers To Pay $499M To Settle Pricing Charges

Law360 (December 21, 2006, 12:00 AM EST) -- Bristol-Myers Squibb Co. has agreed in principle to pay $499 million to settle long-running government investigations into the drug maker’s pricing formulas and sales and marketing activities, the company said Thursday.

Under the proposed deal, the New York-based company will escape criminal charges related to its alleged inflation of average wholesale drug prices, including prices used by government programs and insurers for reimbursement purposes.

The activities prompted several states and counties in New York to take action, with their investigations eventually consolidated by the U.S. Department...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.